NEUROLEUKAEMIOSIS

This adverse event was reported 4 times

These drugs are most commonly taken by patients reporting NEUROLEUKAEMIOSIS:

# Drug Count
0 (DAUNORUBICIN AND CYTARABINE) LIPOSOME 2
1 CYTARABINE 2
2 ATEZOLIZUMAB 1
3 AZACITIDINE 1
4 AZACITIDINE FOR 1
5 BEVACIZUMAB 1
6 CARBOPLATIN 1
7 CASPOFUNGIN ACETATE 1
8 ITRACONAZOLE 1
9 PEMBROLIZUMAB 1
See all common drugs associated with NEUROLEUKAEMIOSIS

NEUROLEUKAEMIOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 (DAUNORUBICIN AND CYTARABINE) LIPOSOME 2 0.0008
1 CASPOFUNGIN ACETATE 1 0.0006
2 VANCOMYCIN HYDROCHLORIDE 1 0.0001
3 ITRACONAZOLE 1 0.0001
4 AZACITIDINE 1 0.0000
5 CYTARABINE 2 0.0000
6 PEMETREXED DISODIUM 1 0.0000
7 ATEZOLIZUMAB 1 0.0000
8 VENETOCLAX 1 0.0000
9 PEMBROLIZUMAB 1 0.0000
See all drugs enriched for association with NEUROLEUKAEMIOSIS